Hakariya, H., Ozaki, A., & Tanimoto, T. (2025). US FDA–accelerated approvals and subsequent withdrawals. Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies, 43(2), 311-317. https://doi.org/10.1007/s10637-025-01524-9
Chicago-referens (17:e uppl.)Hakariya, Hayase, Akihiko Ozaki, och Tetsuya Tanimoto. "US FDA–accelerated Approvals and Subsequent Withdrawals." Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies 43, no. 2 (2025): 311-317. https://doi.org/10.1007/s10637-025-01524-9.
MLA-referens (9:e uppl.)Hakariya, Hayase, et al. "US FDA–accelerated Approvals and Subsequent Withdrawals." Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies, vol. 43, no. 2, 2025, pp. 311-317, https://doi.org/10.1007/s10637-025-01524-9.
